Jump to content

Search the Community

Showing results for tags 'pleomorphic sarcoma'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Blogs

  • Embodi3d Test Blog
  • 3D Printing in Medicine
  • Cool Medical 3D-Printing
  • 3D Bio Printing by Paige Anne Carter
  • SSchoppert's Blog
  • Additive Manufacturing in Medicine
  • biomedical 3D printing
  • Bryce's Blog
  • Chris Leggett
  • 3D Models Help Improve Surgical Precision, Reduce Operating Time
  • Desktop 3D Printing in Medical Imaging
  • 3D Printing: Radiology corner
  • The Embodi3D.com Blog
  • descobar3d's Blog
  • 3D Printing in Anthropology
  • Learn to 3D Print: Basic Tools from software to printers
  • 3D printing for bio-medicine
  • 3D Biomedical Printing - by Jacob M.
  • Valchanov's Blog
  • Deirdre_Manion-Fischer's Blog
  • Matt Johnson's Biomedical 3D Printing Blog
  • Devarsh Vyas's Biomedical 3D Printing Blogs
  • Devarsh Vyas's Biomedical 3D Printing Blogs
  • Mike at Medical Models
  • TOP TEN THE MOST DOWNLOADED EMBODI3D

Forums

  • Biomedical 3D Printing
    • Hardware and 3D Printers
    • democratiz3D®
    • Software
    • Clinical applications
    • 3D Printable Models
    • Medical Imaging: CT, MRI, US
    • Science and Research
    • News and Trending Topics
    • Education, Conferences, Meetings, Events
    • Member Lounge (new!)
    • General
  • Classifieds, Goods and Services
    • General Classifieds - members post free
    • Services needed
    • Services offered
    • Stuff for sale/needed
    • Post a Job
    • Looking for work - visible only to members

Categories

  • democratiz3D® Processing
  • Bones
    • Skull and Head
    • Dental, Orthodontic, Maxillofacial
    • Spine and Pelvis
    • Extremity, Upper (Arm)
    • Extremity, Lower (Leg)
    • Thorax and Ribs
    • Whole body
    • Skeletal tumors, fractures and bony pathology
  • Muscles
    • Head and neck muscles
    • Extremity, Lower (Leg) Muscles
    • Extremity, Upper (Arm) Muscles
    • Thorax and Ribs Muscles
    • Abdomen and Pelvis muscles
    • Whole body Muscles
    • Muscular tumors and sarcomas
  • Cardiac and Vascular
    • Heart
    • Congenital Heart Defects
    • Aorta
    • Mesenteric and abdominal arteries
    • Veins
  • Organs of the Body
    • Brain and nervous system
    • Kidneys
    • Lungs
    • Liver
    • Other organs
  • Skin
  • Veterinary
    • Dogs
    • Cats
    • Other
  • Science and Research
    • Paleontology
    • Anthropology
    • Misc Research
  • Miscellaneous
    • Formlabs
  • Medical CT Scan Files
    • Skull, Head, and Neck CTs
    • Dental, Orthodontic, Maxillofacial CTs
    • Thorax and Ribs CTs
    • Abdomen and Pelvis CTs
    • Extremity, Upper (Arm) CTs
    • Extremity, Lower (Leg) CTs
    • Spine CTs
    • Whole Body CTs
    • MRIs
    • Ultrasound
    • Veterinary/Animals
    • Other

Product Groups

  • Premium Services
  • Physical Print Quotes

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


Found 10 results

  1. Version 1.0.0

    2 downloads

    This 3D model represents a case of undifferentiated pleomorphic spindle cell sarcoma implicating the right parascapular region of a 61 years old male. The patient represented with lung metastasis and was treated by surgical excision follower by chemotherapy as well as radiotherapy. A cross sectional CT image is attached showing the lesion in axial, coronal and sagittal planes. Unfortunately pleomorphic undifferentiated sarcoma has an aggressive biological behaviour and a poor prognosis. Pleomorphic undifferentiated sarcomas can occur almost anywhere in the body, they have a predilection for the retroperitoneum and proximal extremities. They are usually confined to the soft tissues, but occasionally may arise in or from bone. This 3D model was created from the file STS_037 The original CT examination can be reviewed at: The 3D muscle model created from this scan can be reviewed at: The 3D skin model created from this scan can be reviewed at:

    Free

  2. Version 1.0.0

    1 download

    This 3D model represents a case of undifferentiated pleomorphic spindle cell sarcoma implicating the right parascapular region of a 61 years old male. The patient represented with lung metastasis and was treated by surgical excision follower by chemotherapy as well as radiotherapy. A cross sectional CT image is attached showing the lesion in axial, coronal and sagittal planes. Unfortunately pleomorphic undifferentiated sarcoma has an aggressive biological behaviour and a poor prognosis. Pleomorphic undifferentiated sarcomas can occur almost anywhere in the body, they have a predilection for the retroperitoneum and proximal extremities. They are usually confined to the soft tissues, but occasionally may arise in or from bone. This 3D model was created from the file STS_037 The original CT examination can be reviewed at: The 3D bone model created from this scan can be reviewed at: The 3D skin model created from this scan can be reviewed at:

    Free

  3. Version 1.0.0

    1 download

    This 3D model represents a case of undifferentiated pleomorphic spindle cell sarcoma implicating the right parascapular region of a 61 years old male. The patient represented with lung metastasis and was treated by surgical excision follower by chemotherapy as well as radiotherapy. A cross sectional CT image is attached showing the lesion in axial, coronal and sagittal planes. Unfortunately pleomorphic undifferentiated sarcoma has an aggressive biological behaviour and a poor prognosis. Pleomorphic undifferentiated sarcomas can occur almost anywhere in the body, they have a predilection for the retroperitoneum and proximal extremities. They are usually confined to the soft tissues, but occasionally may arise in or from bone. This 3D model was created from the file STS_037 The original CT examination can be reviewed at: The 3D bone model created from this scan can be reviewed at: The 3D muscle model created from this scan can be reviewed at:

    Free

  4. Version 1.0.0

    2 downloads

    This model is the bilateral thigh muscle rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient unfortunately died 9.5 months after diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_023.

    Free

  5. Version 1.0.0

    6 downloads

    This model is the left thigh muscle rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient unfortunately died 9.5 months after diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_023.

    Free

  6. Version 1.0.0

    2 downloads

    This model is the left lower extremity skin rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient is still living with the metastatic disease at 2.5 years since diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_022.

    Free

  7. Version 1.0.0

    1 download

    This model is the bilateral thigh skin rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient is still living with the metastatic disease at 2.5 years since diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_022.

    Free

  8. Version 1.0.0

    3 downloads

    This model is the left lower extremity muscle rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient is still living with the metastatic disease at 2.5 years since diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_022.

    Free

  9. Version 1.0.0

    1 download

    This model is the left thigh muscle rendering of a 65-year-old male with left thigh myxoid fibrosarcoma. At the time of diagnosis, the patient had metastases to his lungs. The patient therefore underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy and was found to have an intermediate grade lesion at the time of diagnosis. The patient is still living with the metastatic disease at 2.5 years since diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Myxoid fibrosarcoma (or myxoid MFH) is the most common subtype of MFH, at about 10%-20% of cases. Clinically, the tumor presents as a deep, slow-growing, painless mass. It is located more commonly in the lower extremities and retroperitoneum. Imaging on MRI demonstrates a mass with low signal intensity on T1-weighting imaging, and high signal intensity on T2-weighted imaging. On histology, a myxoid background is present with a storiform (or cartwheel) pattern seen on low-power imaging, seen in fibrosarcomas. A “myxoid background” is composed of a clear, mucoid substance. Treatment includes radiation, wide surgical resection, and chemotherapy in selected cases. However, the 5-year survival is 50%-60% depending on size, grade, depth and presence of metastasis. The term “malignant fibrous histiocytoma” was coined in the 1960s by Margaret R. Murray when histology a sarcoma demonstrated an appearance like histiocytes, with characteristics of phagocytosis and a pleomorphic pattern. With further research, this entity was identified to have a wider range of appearances with a fibrous characteristic. Today, these sarcomas are known as “pleomorphic sarcomas.” Recently, a change in the understanding of soft tissue tumors has purported that MFH is not a specific type of cancer, but a common morphologic pattern shared by unrelated tumors. One school of thought states that this morphologic pattern is shared by tumors as a common final pathway in cancer progression whereas another school of thought believes that true pleomorphic sarcomas are the result of a transformation from mesenchymal stem cells. Future research into understanding the pathway of these sarcomas and progression will help to target specific therapies and, hopefully, eventual cures. This model was created from the file STS_022.

    Free

  10. Version 1.0.0

    1 download

    This model is the right thigh muscle rendering of a 49-year-old male with a right medial thigh undifferentiated pleomorphic malignant fibrous histiocytoma (MFH). The patient underwent neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy treatment and was found to have a high grade lesion at the time of diagnosis. Metastases to his lungs were also found at diagnosis. The patient is still living with the disease at 2 years since diagnosis. This is an STL file created from DICOM images of his CT scan which may be used for 3D printing. Undifferentiated pleomorphic MFH has more recently been classified as Undifferentiated Pleomorphic Sarcoma. This is the most common soft tissue sarcoma in late adulthood, commonly occurring between 55 to 80 years old and most commonly in Caucasian males. Clinically, it presents as a slowly growing mass in the extremities. Biopsy of the lesion demonstrates, as its name implies, an undifferentiated and pleomorphic appearance. Pleomorphism is the pathologic description of cells and nuclei with variability in size, shape, and staining, which is characteristic of a malignant neoplasm. “Undifferentiated” means that the tissue does not appear like an identifiable tissue structure. Treatment consists of wide resection and radiation. Chemotherapy is added in cases of metastasis, most commonly to the lung. Five-year survival is between 35-60% depending on the grade of tumor and metastases. This model was created from the file STS_021.

    Free

×